Akebia Therapeutics Inc (AKBA.O)

+ 收藏

财务摘要(报告期)(Akebia Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -0.28-0.28-0.20-0.14-0.51-0.47-0.18-0.35
 每股净资产(元) -0.16-0.21-0.14-0.080.050.080.340.14
 每股经营现金净流量(元) -0.12-0.11-0.07-0.09-0.40-0.10-0.28-0.12
 每股现金流量净额(元) -0.25-0.24-0.20-0.18-0.32-0.02-0.030.14
 每股营业收入(元) 1.000.740.510.221.591.291.030.34
盈利能力:
 销售毛利率(%) 61.9059.9261.1251.4471.0262.9873.5049.20
 销售净利率(%) -26.68-37.95-39.48-65.34-31.63-35.81-17.59-101.17
 净资产收益率平均(%) 409.60307.32352.69574.81-215.77-188.26-47.77-121.71
 总资产净利率(%) -17.37-17.78-12.48-8.28-21.10-17.68-6.33-11.77
 投入资本回报率ROIC(%) -22.57-23.36-16.49-10.89-29.06-25.49-8.80-16.95
收益质量:
 营业利润/利润总额(%) 89.0890.6690.9295.1285.4785.6074.1993.71
 经营活动产生的现金流量净额/营业收入(%) -12.02-15.23-14.43-43.71-25.00-7.78-27.74-35.04
资本结构:
 资产负债率(%) 112.65116.78110.57105.1897.3496.8288.0695.12
 权益乘数 -7.90-5.96-9.46-19.2937.6631.478.3820.50
 产权比率 -8.90-6.96-10.46-20.2936.6630.477.3819.50
 流动资产/总资产(%) 48.8846.6446.6943.6052.5754.4958.2956.54
 非流动资产/总资产(%) 51.1253.3653.3156.4047.4345.5141.7143.46
 流动负债/负债合计(%) 36.6829.0432.8628.4836.4344.5450.8549.86
 非流动负债/负债合计(%) 63.3270.9667.1471.5263.5755.4649.1550.14
 归属母公司股东的权益/投入资本(%) -15.39-20.92-13.39-6.533.574.7616.497.24
偿债能力:
 流动比率 1.181.381.281.461.481.261.301.19
 速动比率 1.031.141.061.211.311.051.151.04
 货币资金/流动负债(%) 42.9858.3858.1168.6672.5177.0161.5868.75
 营业利润/流动负债(%) -46.32-59.76-37.53-30.07-63.42-38.71-10.52-23.04
 经营活动产生的现金流量净额/流动负债(%) -23.41-26.44-15.09-21.14-58.64-9.83-22.37-8.51
 归属母公司股东的权益/负债合计(%) -11.23-14.37-9.56-4.932.733.2813.565.13
 经营活动产生的现金流量净额/负债合计(%) -8.59-7.68-4.96-6.02-21.36-4.38-11.38-4.25
 营业利润/负债合计(%) -16.99-17.36-12.33-8.56-23.10-17.24-5.35-11.49
成长能力:
 总资产同比增长率(%) -32.12-46.09-51.38-48.29-33.05-27.62-14.72-14.85
 每股净资产同比增长率(%) -653.38-377.98-142.02-154.23-88.25-90.42-67.05-89.45
 总负债同比增长率(%) -22.39-34.98-38.95-42.81-23.74-9.265.0922.76
 基本每股收益同比增长率(%) 46.1541.67-5.2660.0070.0063.8581.4422.22
 归属母公司股东的权益同比增长率(%) -684.78-384.57-143.03-154.95-87.78-89.90-64.32-87.79
 营业利润同比增长率(%) 42.7437.25-35.6457.3770.1863.4682.969.92
 营业收入同比增长率(%) -33.46-41.52-48.73-34.9637.0054.2079.1117.96
 股东权益合计同比增长率(%) -684.78-384.57-143.03-154.95-87.78-89.90-64.32-87.79
营运能力:
 存货周转率次(次) 3.962.761.760.922.832.251.340.81
 流动资产周转率次(次) 1.280.940.640.261.280.930.650.21
 固定资产周转率次(次) 44.0229.9720.018.0048.9038.3729.479.34
 总资产周转率次(次) 0.660.470.320.130.670.490.360.12
衍生指标:
 现金及现金等价物净增加额TTM(元) -48,590,000.00-99,672,000.00-91,687,000.00-117,985,000.00-58,670,000.00-61,395,000.00-102,051,000.00-77,154,000.00
 利润总额TTM(元) -51,925,000.00-56,946,000.00-96,554,000.00-56,358,000.00-92,562,000.00-155,688,000.00-163,367,000.00-275,681,000.00
 毛利TTM(元) 120,474,000.00143,044,000.00129,441,000.00198,094,000.00207,806,000.00158,786,000.00180,581,000.0072,841,000.00
 投入资本(元) 198,778,000.00188,469,000.00200,140,000.00219,905,000.00261,364,000.00291,133,000.00377,911,000.00360,794,000.00
 经营活动产生的现金流量净额TTM(元) -23,384,000.00-75,755,000.00-34,783,000.00-69,072,000.00-73,154,000.00-81,283,000.00-171,358,000.00-203,839,000.00
 总营业收入TTM(元) 194,623,000.00194,327,000.00200,995,000.00271,030,000.00292,602,000.00297,027,000.00296,819,000.00222,973,000.00
 归属母公司净利润TTM(元) -51,925,000.00-56,946,000.00-96,554,000.00-56,358,000.00-92,562,000.00-155,688,000.00-163,367,000.00-275,681,000.00

前瞻产业研究院